Monkey Protein Blocks HIV

Join Our Community of Science Lovers!

For years, AIDS researchers have struggled with the lack of a good animal model of HIV infection. The ideal candidates, Old World monkeys such as rhesus macaques, are not susceptible to HIV, although they are vulnerable to the monkey version of the virus, known as simian immunodeficiency virus (SIV). Scientists have suspected for some time that monkeys respond to HIV by producing a factor that stops the virus in its tracks. Now they have pinpointed this natural HIV blocker.

In a paper published today in the journal Nature, Joseph Sodroski of Harvard University and his colleagues identify this factor as a protein called TRIM5-alpha. Preventing TRIM5-alpha activity in monkey cells made infection with HIV possible, the researchers report, whereas adding the protein to human cells prevented HIV from taking hold. The protein may function by inhibiting the virus¿s ability to shed its protective coating, which must be removed before the virus can replicate.

TRIM5-alpha stymies HIV but not SIV, which explains why monkeys can contract only one of the two viruses. "The maintenance of a strong block to HIV-1 in Old World monkeys implies a selective advantage, presumably imposed by the presence of HIV-1-like viruses during the evolution of this primate lineage," the scientists write, adding that although humans carry a version of TRIM5-alpha, it is not as effective in thwarting HIV transmission.

On supporting science journalism

If you're enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a subscription you are helping to ensure the future of impactful stories about the discoveries and ideas shaping our world today.

The team¿s discovery lays the foundation for many creative approaches to developing new therapies for HIV infection and AIDS, Sodroski says. One possibility is that monkey TRIM5-alpha could be delivered to HIV patients through gene therapy to rescue as-yet-uninfected cells. Alternatively, Sodroski offers, because humans make a protein that is 87 percent identical, investigators might also focus on rendering the human version of TRIM5-alpha more potent. --Alla Katsnelson

It’s Time to Stand Up for Science

If you enjoyed this article, I’d like to ask for your support. Scientific American has served as an advocate for science and industry for 180 years, and right now may be the most critical moment in that two-century history.

I’ve been a Scientific American subscriber since I was 12 years old, and it helped shape the way I look at the world. SciAm always educates and delights me, and inspires a sense of awe for our vast, beautiful universe. I hope it does that for you, too.

If you subscribe to Scientific American, you help ensure that our coverage is centered on meaningful research and discovery; that we have the resources to report on the decisions that threaten labs across the U.S.; and that we support both budding and working scientists at a time when the value of science itself too often goes unrecognized.

In return, you get essential news, captivating podcasts, brilliant infographics, can't-miss newsletters, must-watch videos, challenging games, and the science world's best writing and reporting. You can even gift someone a subscription.

There has never been a more important time for us to stand up and show why science matters. I hope you’ll support us in that mission.

Thank you,

David M. Ewalt, Editor in Chief, Scientific American